- Chai, Guoliang;
- Webb, Alice;
- Li, Chen;
- Antaki, Danny;
- Lee, Sangmoon;
- Breuss, Martin W;
- Lang, Nhi;
- Stanley, Valentina;
- Anzenberg, Paula;
- Yang, Xiaoxu;
- Marshall, Trevor;
- Gaffney, Patrick;
- Wierenga, Klaas J;
- Chung, Brian Hon-Yin;
- Tsang, Mandy Ho-Yin;
- Pais, Lynn S;
- Lovgren, Alysia Kern;
- VanNoy, Grace E;
- Rehm, Heidi L;
- Mirzaa, Ghayda;
- Leon, Eyby;
- Diaz, Jullianne;
- Neumann, Alexander;
- Kalverda, Arnout P;
- Manfield, Iain W;
- Parry, David A;
- Logan, Clare V;
- Johnson, Colin A;
- Bonthron, David T;
- Valleley, Elizabeth MA;
- Issa, Mahmoud Y;
- Abdel-Ghafar, Sherif F;
- Abdel-Hamid, Mohamed S;
- Jennings, Patricia;
- Zaki, Maha S;
- Sheridan, Eamonn;
- Gleeson, Joseph G
Autosomal-recessive cerebellar hypoplasia and ataxia constitute a group of heterogeneous brain disorders caused by disruption of several fundamental cellular processes. Here, we identified 10 families showing a neurodegenerative condition involving pontocerebellar hypoplasia with microcephaly (PCHM). Patients harbored biallelic mutations in genes encoding the spliceosome components Peptidyl-Prolyl Isomerase Like-1 (PPIL1) or Pre-RNA Processing-17 (PRP17). Mouse knockouts of either gene were lethal in early embryogenesis, whereas PPIL1 patient mutation knockin mice showed neuron-specific apoptosis. Loss of either protein affected splicing integrity, predominantly affecting short and high GC-content introns and genes involved in brain disorders. PPIL1 and PRP17 form an active isomerase-substrate interaction, but we found that isomerase activity is not critical for function. Thus, we establish disrupted splicing integrity and "major spliceosome-opathies" as a new mechanism underlying PCHM and neurodegeneration and uncover a non-enzymatic function of a spliceosomal proline isomerase.